Patient Preference Information Public Workshop – March 31, 2020

ISPOR-FDA Summit 2020

Public Workshop – Using Patient Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond

Today, the U.S. Food and Drug Administration (FDA), along with the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), is announcing a public meeting: Using Patient Preference Information in Medical Device Regulatory Decisions:  Benefit-Risk and Beyond. Workshop Date: Tuesday, March 31, 2020 Location: The FDA’s White Oak Campus in Silver Spring, MD. The meeting will also be live streamed. Registration: No fee for registration. Registration is required for in-person and livestreamed attendance. During this meeting, we will: Discuss and explore potential applications, challenges, and opportunities of using Patient Preference Information (PPI). Hear from stakeholders (including patients, caregivers, health care providers, payers and regulated industries) about The value of including Patient Preference Information in different settings Case studies highlighting the use of Patient Preference Information Methodologies for collecting Patient Preference Information

Learn More and Register

Important Deadlines March 4, 2020: Watch the pre-event webinar PPI Primer at 12:00 p.m. EST. March 17, 2020:  Request special accommodations due to a disability Questions? If you have questions about the public meeting, email CDRH-PPI@fda.hhs.gov